Loading organizations...
§ Venture Capital · Walnut Creek, CA, USA
Venture capital firm managing alumni-specific and diversified funds for accredited individual investors, investing in U.S. tech startups.
Alumni Ventures Group (AVG) provides accredited individual investors access to diversified startup investment portfolios. The firm curates opportunities across various stages and geographies, often co-investing with established VC firms. AVG's model emphasizes rigorous due diligence, simplifying venture investing for its network by identifying promising deals.
Founded in 2014 by Mike Collins and Luke Antal, Alumni Ventures emerged from the observation that high-quality startup investments were inaccessible to individuals. Collins, from TA Associates, aimed to democratize this access, establishing a community-oriented firm connecting startups with an accredited investor base.
AVG serves accredited investors seeking portfolio diversification and returns from the startup ecosystem. The firm acts as a valuable co-investor for entrepreneurs, leveraging its network for strategic support. Alumni Ventures’ vision is to cultivate the world's largest venture network, expanding access to companies, fostering broader VC participation.
AVG Ventures has 3 tracked investments across 1 company. The latest tracked deal is $55.0M Series C in Bellicum Pharmaceuticals in August 2014.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 27, 2014 | Bellicum Pharmaceuticals | $55.0M Series C | — | AJU IB Investment, Jennison Associates, Joseph Edelman, RA Capital Management, Redmile Group, Remeditex Ventures, Ridgeback Capital Investments, Sabby Capital |
| Jan 7, 2014 | Bellicum Pharmaceuticals | $14.7M Series B Extension | — | Remeditex Ventures |
| Mar 8, 2012 | Bellicum Pharmaceuticals | $20.0M Series B | — | James Earl "jim" Brown III, Dennis Stone |